Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-27

FDA Approved: JATENZO — Original Application (TOLMAR Inc.)

View source ↗

Summary

FDA approved JATENZO (testosterone undecanoate) from Tolmar Inc. as an original NDA for testosterone replacement therapy in adult men with hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JATENZO (testosterone undecanoate)

Snippet

ORIG AP for JATENZO (TESTOSTERONE UNDECANOATE)